Earnings Feed
Start Free
U.S. Stem Cell, Inc.·4

Mar 4, 4:01 PM ET

Knutson Gregory 4

4 · U.S. Stem Cell, Inc. · Filed Mar 4, 2022

Insider Transaction Report

Form 4
Period: 2022-02-24
U.S. Stem Cell, Inc.USRM
Knutson Gregory
Director
Transactions
  • Award

    Convertible promissory Note (right to buy)

    2022-02-24$100000.00/sh+12,500,000$1,250,000,000,000→ 16,125,000 total
    Exercise: $0.01From: 2021-02-17Exp: 2024-02-17→ Common Stock (12,500,000 underlying)
  • Award

    Warrant

    2022-02-24+12,500,000→ 28,625,000 total
    Exercise: $0.01From: 2022-02-24Exp: 2023-02-24→ Common Stock (12,500,000 underlying)
Holdings

  • Common Stock

    1,675,000

  • Common Stock

    (indirect: By LLC)
    38,005,331
Footnotes (2)
  • [F1]Previously reported; By addendum the conversion price was adjusted and the maturity date extended.
  • [F2]Issued in consideration of the extension of the extension of the maturity date.

Documents

1 file
  • 4
    ownership.xmlPrimary